MEDI
Harbor Health Care ETF
MEDI seeks long-term capital growth by actively managing a narrow portfolio of stocks engaged in the health care sector globally.
Global
EQUITY
Active
MANAGEMENT STYLE
$ 42.0 M
ASSETS UNDER MGMT
80 bp
EXPENSES
Fund Basics
| Inception date | Nov 17, 2022 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Annually |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| ELI LILLY & CO | 20.3 % |
| ASCENDIS PHARMA AS | 16.8 % |
| GILEAD SCIENCES INC | 4.4 % |
| LEGEND BIOTECH CORPORATION SPONSORED ADR | 4.4 % |
| RHYTHM PHARMACEUTICALS, INC. | 4.1 % |
| ABBVIE INC | 3.5 % |
| INTUITIVE SURGICAL INC | 3.4 % |
| ABIVAX SA-ADR | 3.1 % |
| INSMED INC | 2.9 % |
| BOSTON SCIENTIFIC CORP | 2.7 % |
Constituent Breakdown
| Number of holdings | 37 |
| Herfindahl-Hirschman Index | 856 |
| Wgt avg mkt cap (mns) | $262,205 |
| Large cap (>$10bn) | 62.5% |
| Mid cap ($2-10bn) | 19.4% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 81.9% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 79.0 % |
 |
NETHERLANDS | 1.7 % |
 |
DENMARK | 1.2 % |
Historical Performance
Standardized Performance (as of 06/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 7.6% | 27.1% | 15.2% | 14.6% | -- | -- | -- | 16.1% |
| Dividend Yield | 0.0% | 0.0% | 0.3% | 0.9% | -- | -- | -- | 0.8% |
| Total Returns | 7.6% | 27.1% | 15.5% | 15.5% | -- | -- | -- | 16.9% | Ann. Volatility | 22.8% | 20.4% | 21.3% | 19.3% | -- | -- | -- | 18.7% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.62 | 15% |
| MSCI EAFE | 0.61 | 21% |
| MSCI Emg Mkts | 0.22 | 6% |
Liquidity Measures
| Avg. volume (000) | 4 |
| ADV traded (mns) | $0 |
| Turnover | 0.3% |
| Avg. Bid/Ask (% of price) | 0.21% |
Technical Indicators
| 30d moving avg. (EMA) | $32.86 |
| Relative strength (RSI) | 58 |
| MACD/Signal | 0.62/0.79 |
| Bollinger Bands (Upper/Lower) | $35.80/$31.07 |
| Short interest (% of AUM) | 0.3% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. MEDI |
Expenses vs. MEDI |
ALTAR Score™ vs. MEDI |
|---|---|---|---|---|
| IYH | iShares U.S. Healthcare ETF | 36.5% | -40 bp | +7.0% |
| HRTS | Tema Heart & Health ETF | 35.9% | -5 bp | +4.1% |
| FHLC | Fidelity MSCI Health Care Index ETF | 35.5% | -72 bp | +7.2% |
| XLV | Health Care Select Sector SPDR | 35.4% | -72 bp | +7.7% |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 35.3% | -5 bp | +2.3% |
| VHT | Vanguard Health Care ETF | 34.8% | -71 bp | +6.2% |
| PPH | VanEck Pharmaceutical ETF | 28.7% | -44 bp | +8.6% |
| IXJ | iShares Global Healthcare ETF | 27.8% | -38 bp | +7.7% |
| MEDX | Horizon Kinetics Medical ETF | 26.1% | +5 bp | +2.3% |
| FMED | Fidelity Disruptive Medicine ETF | 25.4% | -30 bp | -0.3% |
Risk and Returns: MEDI vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 7/22/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
-0.9%
ALTAR SCORE™
2nd
PERCENTILE
AVOID
ETFRC RATING
There are 735 funds in the Global Equity category with an average
ALTAR Score™ of 4.4% and a standard deviation
of 2.6%. MEDI's ALTAR Score™ is approximately -2.0 standard
deviations above the category average. This places MEDI in the 2nd percentile
among funds in the category.
Sell-Side Consensus
$39.87
PRICE TARGET
+20.3%
UPSIDE
Bid/Ask Spreads
21 bp
AVG SPREAD
13 —
121 bp
RANGE